Enterobacteriaceae. Medical search

A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock.

Infections with bacteria of the family ENTEROBACTERIACEAE.

Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins.

Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).

Substances that reduce the growth or reproduction of BACTERIA.

Nonsusceptibility of bacteria to the action of the beta-lactam antibiotics. Mechanisms responsible for beta-lactam resistance may be degradation of antibiotics by BETA-LACTAMASES, failure of antibiotics to penetrate, or low-affinity binding of antibiotics to targets.

Gram-negative gas-producing rods found in feces of humans and other animals, sewage, soil, water, and dairy products.

A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the natural environment (soil, water, and plant surfaces) or as an opportunistic human pathogen.

A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the intestines of humans and a wide variety of animals, as well as in manure, soil, and polluted waters. Its species are pathogenic, causing urinary tract infections and are also considered secondary invaders, causing septic lesions at other sites of the body.

A group of beta-lactam antibiotics in which the sulfur atom in the thiazolidine ring of the penicillin molecule is replaced by a carbon atom. THIENAMYCINS are a subgroup of carbapenems which have a sulfur atom as the first constituent of the side chain.

Techniques used in studying bacteria.

A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms arrange singly, in pairs, or short chains. This genus is commonly found in the intestinal tract and is an opportunistic pathogen that can give rise to bacteremia, pneumonia, urinary tract and several other types of human infection.

A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms occur in the lower part of the intestine of warm-blooded animals. The species are either nonpathogenic or opportunistic pathogens.

Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.

Four-membered cyclic AMIDES, best known for the PENICILLINS based on a bicyclo-thiazolidine, as well as the CEPHALOSPORINS based on a bicyclo-thiazine, and including monocyclic MONOBACTAMS. The BETA-LACTAMASES hydrolyze the beta lactam ring, accounting for BETA-LACTAM RESISTANCE of infective bacteria.

A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.

Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method.

A genus of gram-negative, rod-shaped enterobacteria that can use citrate as the sole source of carbon.

One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.

A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.

The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).

The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).

The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).

A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that utilizes citrate as a sole carbon source. It is pathogenic for humans, causing enteric fevers, gastroenteritis, and bacteremia. Food poisoning is the most common clinical manifestation. Organisms within this genus are separated on the basis of antigenic characteristics, sugar fermentation patterns, and bacteriophage susceptibility.

A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in water, sewage, soil, meat, hospital environments, and on the skin and in the intestinal tract of man and animals as a commensal.

Infections with bacteria of the genus KLEBSIELLA.

A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in soil, water, food, and clinical specimens. It is a prominent opportunistic pathogen for hospitalized patients.

Proteins found in any species of bacterium.

Deoxyribonucleic acid that makes up the genetic material of bacteria.

Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method.

A family of gram-negative bacteria whose members predominate in the bacterial flora of PLANKTON; FISHES; and SEAWATER. Some members are important pathogens for humans and animals.

Studies determining the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. For drugs and devices, CLINICAL TRIALS AS TOPIC; DRUG EVALUATION; and DRUG EVALUATION, PRECLINICAL are available.

A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.

Semisynthetic broad-spectrum cephalosporin.

Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.

A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is frequently isolated from clinical specimens. Its most common site of infection is the urinary tract.

A species of gram-negative bacteria causing URINARY TRACT INFECTIONS and SEPTICEMIA.

Gram-negative rods isolated from human urine and feces.

A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that ferments sugar without gas production. Its organisms are intestinal pathogens of man and other primates and cause bacillary dysentery (DYSENTERY, BACILLARY).

Non-susceptibility of an organism to the action of the cephalosporins.

Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.

A genus of gram-negative, facultatively anaerobic bacteria in the family ENTEROBACTERIACEAE. It is found in FOOD; SOIL; and SEWAGE; and is an opportunistic pathogen of humans.

A family of gram-negative bacteria usually found in soil or water and including many plant pathogens and a few animal pathogens.

A species of gram-negative, facultatively anaerobic, rod-shaped bacteria found in humans and other animals including MAMMALS; BIRDS; REPTILES; and AMPHIBIANS. It has also been isolated from SOIL and WATER as well as from clinical specimens such as URINE; THROAT; SPUTUM; BLOOD; and wound swabs as an opportunistic pathogen.

Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.

A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection.

A building block of penicillin, devoid of significant antibacterial activity. (From Merck Index, 11th ed)

Any infection which a patient contracts in a health-care institution.

Beta-lactam antibiotics that differ from PENICILLINS in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors.

Bicyclic bridged compounds that contain a nitrogen which has three bonds. The nomenclature indicates the number of atoms in each path around the rings, such as [2.2.2] for three equal length paths. Some members are TROPANES and BETA LACTAMS.

A parasexual process in BACTERIA; ALGAE; FUNGI; and ciliate EUKARYOTA for achieving exchange of chromosome material during fusion of two cells. In bacteria, this is a uni-directional transfer of genetic material; in protozoa it is a bi-directional exchange. In algae and fungi, it is a form of sexual reproduction, with the union of male and female gametes.

A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.

Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.

Bacteria which retain the crystal violet stain when treated by Gram's method.

Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.

A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms are associated with plants as pathogens, saprophytes, or as constituents of the epiphytic flora.

Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.

Clavulanic acid and its salts and esters. The acid is a suicide inhibitor of bacterial beta-lactamase enzymes from Streptomyces clavuligerus. Administered alone, it has only weak antibacterial activity against most organisms, but given in combination with other beta-lactam antibiotics it prevents antibiotic inactivation by microbial lactamase.

Infections by bacteria, general or unspecified.

Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.

A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.

The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.

A genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity.

The destruction of germs causing disease.

Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics.

A group of QUINOLONES with at least one fluorine atom and a piperazinyl group.

A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis.

Institutions with an organized medical staff which provide medical care to patients.

Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components.

A broad-spectrum antimicrobial carboxyfluoroquinoline.

A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.

The naturally occurring transmission of genetic information between organisms, related or unrelated, circumventing parent-to-offspring transmission. Horizontal gene transfer may occur via a variety of naturally occurring processes such as GENETIC CONJUGATION; GENETIC TRANSDUCTION; and TRANSFECTION. It may result in a change of the recipient organism's genetic composition (TRANSFORMATION, GENETIC).

A method where a culturing surface inoculated with microbe is exposed to small disks containing known amounts of a chemical agent resulting in a zone of inhibition (usually in millimeters) of growth of the microbe corresponding to the susceptibility of the strain to the agent.

A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

DNA elements that include the component genes and insertion site for a site-specific recombination system that enables them to capture mobile gene cassettes.

The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species.

A genus of gram-negative, facultatively anaerobic rod- to coccobacillus-shaped bacteria that occurs in a broad spectrum of habitats.

Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens (not to be confused with pigment-synthesizing bacteria also called chromogens).

The functional hereditary units of BACTERIA.

In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.

A complex sulfated polymer of galactose units, extracted from Gelidium cartilagineum, Gracilaria confervoides, and related red algae. It is used as a gel in the preparation of solid culture media for microorganisms, as a bulk laxative, in making emulsions, and as a supporting medium for immunodiffusion and immunoelectrophoresis.

Procedures for identifying types and strains of bacteria. The most frequently employed typing systems are BACTERIOPHAGE TYPING and SEROTYPING as well as bacteriocin typing and biotyping.

A semisynthetic cephamycin antibiotic resistant to beta-lactamase.

Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID.

Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.

Using MOLECULAR BIOLOGY techniques, such as DNA SEQUENCE ANALYSIS; PULSED-FIELD GEL ELECTROPHORESIS; and DNA FINGERPRINTING, to identify, classify, and compare organisms and their subtypes.

Gel electrophoresis in which the direction of the electric field is changed periodically. This technique is similar to other electrophoretic methods normally used to separate double-stranded DNA molecules ranging in size up to tens of thousands of base-pairs. However, by alternating the electric field direction one is able to separate DNA molecules up to several million base-pairs in length.

A genus of gram-negative, aerobic, rod-shaped bacteria widely distributed in nature. Some species are pathogenic for humans, animals, and plants.

Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It has been proposed especially against Pseudomonas infections.

A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in soil, fecal matter, and sewage. It is an opportunistic pathogen and causes cystitis and pyelonephritis.

Infections with bacteria of the species ESCHERICHIA COLI.

Direct nucleotide sequencing of gene fragments from multiple housekeeping genes for the purpose of phylogenetic analysis, organism identification, and typing of species, strain, serovar, or other distinguishable phylogenetic level.

A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs singly, in pairs, or in short chains. Its organisms are found in fresh water and sewage and are pathogenic to humans, frogs, and fish.

A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.

An antibiotic derived from penicillin similar to CARBENICILLIN in action.

A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER.

Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function.

Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.

Constituent of 30S subunit prokaryotic ribosomes containing 1600 nucleotides and 21 proteins. 16S rRNA is involved in initiation of polypeptide synthesis.

Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing.

A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone.

A cephalosporin antibiotic.

The type species for the genus HAFNIA. It is distinguished from other biochemically similar bacteria by its lack of acid production on media containing sucrose. (From Bergey's Manual of Determinative Bacteriology, 9th ed)

The presence of bacteria, viruses, and fungi in food and food products. This term is not restricted to pathogenic organisms: the presence of various non-pathogenic bacteria and fungi in cheeses and wines, for example, is included in this concept.

Gram-negative, capsulated, gas-producing rods found widely in nature. Both motile and non-motile strains exist. The species is closely related to KLEBSIELLA PNEUMONIAE and is frequently associated with nosocomial infections

Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams.

Monocyclic, bacterially produced or semisynthetic beta-lactam antibiotics. They lack the double ring construction of the traditional beta-lactam antibiotics and can be easily synthesized.

A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.

A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)

A class of plasmids that transfer antibiotic resistance from one bacterium to another by conjugation.

The relationships of groups of organisms as reflected by their genetic makeup.

A large group of aerobic bacteria which show up as pink (negative) when treated by the gram-staining method. This is because the cell walls of gram-negative bacteria are low in peptidoglycan and thus have low affinity for violet stain and high affinity for the pink dye safranine.

Generally refers to the digestive structures stretching from the MOUTH to ANUS, but does not include the accessory glandular organs (LIVER; BILIARY TRACT; PANCREAS).

Acids, salts, and derivatives of clavulanic acid (C8H9O5N). They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects.

Hospitals maintained by a university for the teaching of medical students, postgraduate training programs, and clinical research.

Infection within the PERITONEAL CAVITY. A frequent cause is an ANASTOMOTIC LEAK following surgery.

A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.

Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.

Antibiotic produced by Micromonospora inyoensis. It is closely related to gentamicin C1A, one of the components of the gentamicin complex (GENTAMICINS).

A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.

Narrow pieces of material impregnated or covered with a substance used to produce a chemical reaction. The strips are used in detecting, measuring, producing, etc., other substances. (From Dorland, 28th ed)

The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host.

A republic in central Africa south of CHAD and SUDAN, north of DEMOCRATIC REPUBLIC OF THE CONGO, and east of CAMEROON. The capital is Bangui.

Xanthene dye used as a bacterial and biological stain. Synonyms: Pyronin; Pyronine G; Pyronine Y. Use also for Pyronine B. which is diethyl-rather than dimethylamino-.

The application of molecular biology to the answering of epidemiological questions. The examination of patterns of changes in DNA to implicate particular carcinogens and the use of molecular markers to predict which individuals are at highest risk for a disease are common examples.

A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.

Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use.

Broad- spectrum beta-lactam antibiotic similar in structure to the CEPHALOSPORINS except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain CEPHALOSPORINS. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections.

An amidinopenicillanic acid derivative with broad spectrum antibacterial action.

The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.

A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE.

A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.

Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms.

Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point.

A technique for identifying individuals of a species that is based on the uniqueness of their DNA sequence. Uniqueness is determined by identifying which combination of allelic variations occur in the individual at a statistically relevant number of different loci. In forensic studies, RESTRICTION FRAGMENT LENGTH POLYMORPHISM of multiple, highly polymorphic VNTR LOCI or MICROSATELLITE REPEAT loci are analyzed. The number of loci used for the profile depends on the ALLELE FREQUENCY in the population.

Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate.

Proteins obtained from ESCHERICHIA COLI.

Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)

Liquid by-product of excretion produced in the kidneys, temporarily stored in the bladder until discharge through the URETHRA.

Any infection acquired in the community, that is, contrasted with those acquired in a health care facility (CROSS INFECTION). An infection would be classified as community-acquired if the patient had not recently been in a health care facility or been in contact with someone who had been recently in a health care facility.

Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.

UK-18892, a new aminoglycoside: an in vitro study. (1/3467)

UK-18892 is a new aminoglycoside antibiotic, a derivative of kanamycin A structurally related to amikacin. It was found to be active against a wide range of pathogenic bacteria, including many gentamicin-resistant strains. The spectrum and degree of activity of UK-18892 were similar to those of amikacin, and differences were relatively minor. UK-18892 was about twice as active as amikacin against gentamicin-susceptible strains of Pseudomonas aeruginosa. Both amikacin and UK-18892 were equally active against gentamicin-resistant strains of P. aeruginosa. There were no appreciable differences in the activity of UK-18892 and amikacin against Enterobacteriaceae and Staphylococcus aureus. Cross-resistance between these two antimicrobials was also apparent. (+info)

Ciprofloxacin decreases the rate of ethanol elimination in humans. (2/3467)

BACKGROUND: Extrahepatic ethanol metabolism is postulated to take place via microbial oxidation in the colon, mediated by aerobic and facultative anaerobic bacteria. AIMS: To evaluate the role of microbial ethanol oxidation in the total elimination rate of ethanol in humans by reducing gut flora with ciprofloxacin. METHODS: Ethanol was administered intravenously at the beginning and end of a one week period to eight male volunteers. Between ethanol doses volunteers received 750 mg ciprofloxacin twice daily. RESULTS: A highly significant (p=0.001) reduction in the ethanol elimination rate (EER) was detected after ciprofloxacin medication. Mean (SEM) EER was 107.0 (5.3) and 96.9 (4.8) mg/kg/h before and after ciprofloxacin, respectively. Faecal Enterobacteriaceae and Enterococcus sp. were totally absent after medication, and faecal acetaldehyde production capacity was significantly (p<0.05) decreased from 0.91 (0.15) to 0.39 (0.08) nmol/min/mg protein. Mean faecal alcohol dehydrogenase (ADH) activity was significantly (p<0. 05) decreased after medication, but ciprofloxacin did not inhibit human hepatic ADH activity in vitro. CONCLUSIONS: Ciprofloxacin treatment decreased the ethanol elimination rate by 9.4%, with a concomitant decrease in intestinal aerobic and facultative anaerobic bacteria, faecal ADH activity, and acetaldehyde production. As ciprofloxacin has no effect on liver blood flow, hepatic ADH activity, or cytochrome CYP2E1 activity, these effects are probably caused by the reduction in intestinal flora. (+info)

Sodalis gen. nov. and Sodalis glossinidius sp. nov., a microaerophilic secondary endosymbiont of the tsetse fly Glossina morsitans morsitans. (3/3467)

A secondary intracellular symbiotic bacterium was isolated from the haemolymph of the tsetse fly Glossina morsitans morsitans and cultured in Aedes albopictus cell line C6/36. Pure-culture isolation of this bacterium was achieved through the use of solid-phase culture under a microaerobic atmosphere. After isolation of strain M1T, a range of tests was performed to determine the phenotypic properties of this bacterium. Considering the results of these tests, along with the phylogenetic position of this micro-organism, it is proposed that this intracellular symbiont from G. m. morsitans should be classified in a new genus Sodalis gen. nov., as Sodalis glossinidius gen. nov., sp. nov. Strain M1T is the type strain for this new species. (+info)

High turnover rate of Escherichia coli strains in the intestinal flora of infants in Pakistan. (4/3467)

The Escherichia coli flora of infants in developed countries is dominated by one or a few strains which persist for prolonged periods of time, but no longitudinal studies have been performed in developing countries. To this end, we studied the rectal enterobacterial flora in 22 home-delivered Pakistani infants during their first 6 months of life. Three colonies were isolated and species typed on each of 11 sampling occasions. E. coli isolates were strain typed using electromorphic typing of cytoplasmic enzymes, and their O serogroups were determined. There was a very rapid turnover of enterobacterial strains in the rectal flora of individual infants. On average, 8.5 different E. coli strains were found per infant, and several biotypes of other enterobacteria. Less than 50% of the infants were colonized with E. coli from their mothers, but strains of maternal origin were four times more likely to persists in the infants' flora than other E. coli strains. Enterobacteria other than E. coli were always of non-maternal origin, and Enterobacter cloacae and Klebsiella pneumoniae biotypes recovered from contaminated feeds were later identified in the infants' rectal flora. An early colonization with klebsiella or enterobacter was significantly associated with diarrhoea during the neonatal period, although these bacteria were not likely to be the cause of the disease. The results suggest that poor hygienic conditions result in an unstable and diverse enterobacterial flora, which may influence infant health. (+info)

The influence of a diet rich in wheat fibre on the human faecal flora. (5/3467)

The effect on the faecal flora of adding wheat fibre to a controlled diet in four healthy volunteers for a 3-week period has been observed. No change in the concentration of the bacteria in the bacterial groups counted was found, although there was a slight increase in total output associated with increased faecal weight. The predominant organisms in all subjects were non-sporing anaerobes, but the dominant species in each subject was different and was unaffected by changing the diet. Similarly, the concentration of faecal beta-glucuronidase detected in two subjects was unaltered and the concentration of clostridia able to dehydrogenate the steroid nucleus found in one subject was unaltered. It is suggested that the faecal microflora is not primarily controlled by the presence of undigested food residues in the large bowel. (+info)

Use of an isogenic Escherichia coli panel to design tests for discrimination of beta-lactamase functional groups of Enterobacteriaceae. (6/3467)

A study was designed to determine if an isogenic panel of Escherichia coli strains containing many different beta-lactamases could be used for the preliminary screening of a large number of beta-lactam agents to identify which might be most useful in the development of a definitive test for specific beta-lactamases found among the members of family Enterobacteriaceae. The susceptibilities of 46 strains, comprising the isogenic panel, to expanded-spectrum cephalosporins, cephamycins, and aztreonam were determined in the presence and absence of beta-lactamase inhibitors in broth microdilution tests. The results indicated that strains producing extended-spectrum beta-lactamases (ESBLs) could be distinguished from strains producing other Bush-Jacoby-Medeiros functional group 2 or group 1 beta-lactamases. For strains producing group 1 beta-lactamases, cefpodoxime and ceftazidime MICs were > or = 4 micrograms/ml and addition of clavulanate did not reduce the MICs more than fourfold. For strains producing group 2 enzymes other than ESBLs, cefpodoxime and ceftazidime MICs were < or = 2 micrograms/ml. With a single exception (ceftazidime for the strain producing SHV-3), among strains producing ESBLs, cefpodoxime and ceftazidime MICs were > or = 4 micrograms/ml and addition of clavulanate reduced the MICs by more than eightfold. Cephamycins could also be used to discriminate between strains producing group 1 beta-lactamases and ESBLs, since only the former required cefotetan concentrations as high as 8 micrograms/ml or cefoxitin concentrations of > 16 micrograms/ml for inhibition. Other cephalosporins provided some discrimination between the various beta-lactamase producers, although they were not as reliable as either cefpodoxime or ceftazidime. These results indicate the utility of an isogenic panel for identification of candidate drugs among many for further testing with clinical isolates of the family Enterobacteriaceae to determine the best agents for detection of specific beta-lactamases in this family. (+info)

Many class I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe. (7/3467)

Three sizes of inserted regions of DNA (800, 1,000, and 1,500 bp) were shown to be common among class I integrons in unrelated clinical isolates of Enterobacteriaceae from different European hospitals. Sequencing showed that 800-bp inserted regions comprised identical sequences including aacA4, that 1,000-bp inserted regions included aadA, and that 1,500-bp inserted regions included dfrI and aadA1, irrespective of host species and geographic origin. In addition promoter sequences were mostly identical for each size class. These data suggest that inserted gene cassettes and promoter regions of integrons are conserved and stable, with resistance genes transferred more often as part of the entire integron structure than as individual gene cassettes. (+info)

Functional importance and local environments of the cysteines in the tetracycline resistance protein encoded by plasmid pBR322. (8/3467)

The properties of the cysteines in the pBR322-encoded tetracycline resistance protein have been examined. Cysteines are important but not essential for tetracycline transport activity. None of the cysteines reacted with biotin maleimide, suggesting that they are shielded from the aqueous phase or reside in a negatively charged local environment. (+info)

Previous article'Etiology' Next article 'Esophageal Cancer'

Klebsiella Infections can occur in anyone, but certain groups of people are at higher risk, such as premature infants, people with weakened immune systems, and those with chronic medical conditions like diabetes, liver or kidney disease.

Symptoms of Klebsiella Infections include fever, chills, cough, difficulty breathing, painful urination, redness and swelling in the affected area, and in severe cases, sepsis and death.

Diagnosis of Klebsiella Infections is typically made through a combination of physical examination, medical history, and laboratory tests, such as blood cultures and urine cultures.

Treatment of Klebsiella Infections usually involves antibiotics, which can help clear the infection and prevent it from spreading. In severe cases, hospitalization may be necessary to provide appropriate care and monitoring.

Prevention of Klebsiella Infections includes good hand hygiene, proper cleaning and disinfection of equipment and surfaces, and avoiding close contact with individuals who have the infection. Vaccines are also available for certain types of Klebsiella Infections, such as pneumonia.

Complications of Klebsiella Infections can include pneumonia, urinary tract infections, bloodstream infections, and sepsis, which can lead to organ failure and death if left untreated.

Recovery from Klebsiella Infections usually occurs within a few days to a week after antibiotic treatment is started, but in severe cases, recovery may take longer and may require hospitalization and close monitoring.

In conclusion, Klebsiella Infections are a type of bacterial infection that can affect various parts of the body, and can be mild or severe. Prompt diagnosis and treatment with antibiotics are essential to prevent complications and ensure a successful recovery. Proper hygiene practices and vaccines are also important for preventing the spread of these infections.

Gram-negative bacterial infections can be difficult to treat because these bacteria are resistant to many antibiotics. In addition, some gram-negative bacteria produce enzymes called beta-lactamases, which break down the penicillin ring of many antibiotics, making them ineffective against the infection.

Some common types of gram-negative bacterial infections include:

* Pneumonia
* Urinary tract infections (UTIs)
* Bloodstream infections (sepsis)
* Meningitis
* Skin and soft tissue infections
* Respiratory infections, such as bronchitis and sinusitis

Examples of gram-negative bacteria that can cause infection include:

* Escherichia coli (E. coli)
* Klebsiella pneumoniae
* Pseudomonas aeruginosa
* Acinetobacter baumannii
* Proteus mirabilis

Gram-negative bacterial infections can be diagnosed through a variety of tests, including blood cultures, urine cultures, and tissue samples. Treatment typically involves the use of broad-spectrum antibiotics, such as carbapenems or cephalosporins, which are effective against many types of gram-negative bacteria. In some cases, the infection may require hospitalization and intensive care to manage complications such as sepsis or organ failure.

Prevention of gram-negative bacterial infections includes good hand hygiene, proper use of personal protective equipment (PPE), and appropriate use of antibiotics. In healthcare settings, infection control measures such as sterilization and disinfection of equipment, and isolation precautions for patients with known gram-negative bacterial infections can help prevent the spread of these infections.

Overall, gram-negative bacterial infections are a significant public health concern, and proper diagnosis and treatment are essential to prevent complications and reduce the risk of transmission.

In medicine, cross-infection refers to the transmission of an infectious agent from one individual or source to another, often through direct contact or indirect exposure. This type of transmission can occur in various settings, such as hospitals, clinics, and long-term care facilities, where patients with compromised immune systems are more susceptible to infection.

Cross-infection can occur through a variety of means, including:

1. Person-to-person contact: Direct contact with an infected individual, such as touching, hugging, or shaking hands.
2. Contaminated surfaces and objects: Touching contaminated surfaces or objects that have been touched by an infected individual, such as doorknobs, furniture, or medical equipment.
3. Airborne transmission: Inhaling droplets or aerosolized particles that contain the infectious agent, such as during coughing or sneezing.
4. Contaminated food and water: Consuming food or drinks that have been handled by an infected individual or contaminated with the infectious agent.
5. Insect vectors: Mosquitoes, ticks, or other insects can transmit infections through their bites.

Cross-infection is a significant concern in healthcare settings, as it can lead to outbreaks of nosocomial infections (infections acquired in hospitals) and can spread rapidly among patients, healthcare workers, and visitors. To prevent cross-infection, healthcare providers use strict infection control measures, such as wearing personal protective equipment (PPE), thoroughly cleaning and disinfecting surfaces, and implementing isolation precautions for infected individuals.

In summary, cross-infection refers to the transmission of an infectious agent from one individual or source to another, often through direct contact or indirect exposure in healthcare settings. Preventing cross-infection is essential to maintaining a safe and healthy environment for patients, healthcare workers, and visitors.

Some common examples of bacterial infections include:

1. Urinary tract infections (UTIs)
2. Respiratory infections such as pneumonia and bronchitis
3. Skin infections such as cellulitis and abscesses
4. Bone and joint infections such as osteomyelitis
5. Infected wounds or burns
6. Sexually transmitted infections (STIs) such as chlamydia and gonorrhea
7. Food poisoning caused by bacteria such as salmonella and E. coli.

In severe cases, bacterial infections can lead to life-threatening complications such as sepsis or blood poisoning. It is important to seek medical attention if symptoms persist or worsen over time. Proper diagnosis and treatment can help prevent these complications and ensure a full recovery.

Bacteremia can occur when bacteria enter the bloodstream through various means, such as:

* Infected wounds or surgical sites
* Injecting drug use
* Skin infections
* Respiratory tract infections
* Urinary tract infections
* Endocarditis (infection of the heart valves)

The symptoms of bacteremia can vary depending on the type of bacteria and the severity of the infection. Some common symptoms include:

* Fever
* Chills
* Headache
* Muscle aches
* Weakness
* Confusion
* Shortness of breath

Bacteremia is diagnosed by blood cultures, which involve collecting blood samples and inserting them into a specialized container to grow the bacteria. Treatment typically involves antibiotics and supportive care, such as intravenous fluids and oxygen therapy. In severe cases, hospitalization may be necessary to monitor and treat the infection.

Prevention measures for bacteremia include:

* Practicing good hygiene, such as washing hands regularly
* Avoiding sharing personal items like toothbrushes or razors
* Properly cleaning and covering wounds
* Getting vaccinated against infections that can lead to bacteremia
* Following proper sterilization techniques during medical procedures

Overall, bacteremia is a serious condition that requires prompt medical attention to prevent complications and ensure effective treatment.

Here are some common types of E. coli infections:

1. Urinary tract infections (UTIs): E. coli is a leading cause of UTIs, which occur when bacteria enter the urinary tract and cause inflammation. Symptoms include frequent urination, burning during urination, and cloudy or strong-smelling urine.
2. Diarrheal infections: E. coli can cause diarrhea, abdominal cramps, and fever if consumed through contaminated food or water. In severe cases, this type of infection can lead to dehydration and even death, particularly in young children and the elderly.
3. Septicemia (bloodstream infections): If E. coli bacteria enter the bloodstream, they can cause septicemia, a life-threatening condition that requires immediate medical attention. Symptoms include fever, chills, rapid heart rate, and low blood pressure.
4. Meningitis: In rare cases, E. coli infections can spread to the meninges, the protective membranes covering the brain and spinal cord, causing meningitis. This is a serious condition that requires prompt treatment with antibiotics and supportive care.
5. Hemolytic-uremic syndrome (HUS): E. coli infections can sometimes cause HUS, a condition where the bacteria destroy red blood cells, leading to anemia, kidney failure, and other complications. HUS is most common in young children and can be fatal if not treated promptly.

Preventing E. coli infections primarily involves practicing good hygiene, such as washing hands regularly, especially after using the bathroom or before handling food. It's also essential to cook meat thoroughly, especially ground beef, to avoid cross-contamination with other foods. Avoiding unpasteurized dairy products and drinking contaminated water can also help prevent E. coli infections.

If you suspect an E. coli infection, seek medical attention immediately. Your healthcare provider may perform a urine test or a stool culture to confirm the diagnosis and determine the appropriate treatment. In mild cases, symptoms may resolve on their own within a few days, but antibiotics may be necessary for more severe infections. It's essential to stay hydrated and follow your healthcare provider's recommendations to ensure a full recovery.

Symptoms of a UTI can include:

* Painful urination
* Frequent urination
* Cloudy or strong-smelling urine
* Blood in the urine
* Pelvic pain in women
* Rectal pain in men

If you suspect that you have a UTI, it is important to seek medical attention as soon as possible. UTIs can lead to more serious complications if left untreated, such as kidney damage or sepsis.

Treatment for a UTI typically involves antibiotics to clear the infection. It is important to complete the full course of treatment to ensure that the infection is completely cleared. Drinking plenty of water and taking over-the-counter pain relievers may also help alleviate symptoms.

Preventive measures for UTIs include:

* Practicing good hygiene, such as wiping from front to back and washing hands after using the bathroom
* Urinating when you feel the need, rather than holding it in
* Avoiding certain foods that may irritate the bladder, such as spicy or acidic foods
* Drinking plenty of water to help flush bacteria out of the urinary tract.

Intra-abdominal infections can be caused by a variety of microorganisms, including bacteria such as Escherichia coli, Klebsiella, and Staphylococcus aureus, and fungi such as Candida. The infection can spread to the abdominal cavity through various means, such as direct extension from an adjacent infected site, hematogenous spread (through the bloodstream), or contamination during surgery or other medical procedures.

The symptoms of intra-abdominal infections can vary depending on the location and severity of the infection, but may include fever, abdominal pain, nausea, vomiting, and diarrhea. In severe cases, the infection can lead to life-threatening complications such as sepsis (a systemic inflammatory response to infection) and organ failure.

Diagnosis of intra-abdominal infections typically involves a combination of physical examination, laboratory tests (such as blood cultures and abdominal imaging studies), and surgical exploration. Treatment usually involves antibiotics and/or surgical drainage of the infected site, and may also involve supportive care such as fluid replacement and management of complications.

Some common types of intra-abdominal infections include:

* Peritonitis: inflammation of the peritoneum, often caused by bacterial infection.
* Abscesses: pockets of pus that form in the abdominal cavity as a result of infection.
* Gastrointestinal (GI) infections: infections of the GI tract, such as appendicitis and diverticulitis.
* Urinary tract infections (UTIs): infections of the urinary system that can spread to the abdominal cavity.

Other names for intra-abdominal infections include:

* Abdominal infections
* Intra-abdominal sepsis
* Peritoneal infections
* Gastrointestinal infections

It is important to seek medical attention if you suspect that you or someone else may have an intra-abdominal infection, as prompt treatment can help prevent serious complications and improve outcomes.

Examples of CAIs include:

1. Respiratory infections such as bronchitis, pneumonia, and influenza.
2. Skin and soft tissue infections such as cellulitis, abscesses, and wound infections.
3. Gastrointestinal infections such as food poisoning, diarrhea, and gastroenteritis.
4. Urinary tract infections (UTIs) caused by bacteria that enter the urinary tract through the urethra or bladder.
5. Sexually transmitted infections (STIs) such as chlamydia, gonorrhea, and syphilis.
6. Bacterial infections such as staphylococcus aureus, streptococcus pneumoniae, and haemophilus influenzae.
7. Viral infections such as herpes simplex virus (HSV), human papillomavirus (HPV), and norovirus.

CAIs can be treated with antibiotics, antivirals, or other medications depending on the cause of the infection. It's important to seek medical attention if symptoms persist or worsen over time, as untreated CAIs can lead to serious complications and potentially life-threatening conditions.

Media related to Enterobacteriaceae at Wikimedia Commons Enterobacteriaceae genomes and related information at PATRIC, a ... Enterobacteriaceae is a large family of Gram-negative bacteria. It was first proposed by Rahn in 1936, and now includes over 30 ... Members of the Enterobacteriaceae are bacilli (rod-shaped), and are typically 1-5 μm in length. They typically appear as medium ... Most members of Enterobacteriaceae have peritrichous, type I fimbriae involved in the adhesion of the bacterial cells to their ...

https://en.wikipedia.org/wiki/Enterobacteriaceae

... (CRE) or carbapenemase-producing Enterobacteriaceae (CPE) are Gram-negative bacteria ... Extended-Spectrum β-lactamase-Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant ... Enterobacteriaceae are most commonly found in the intestinal flora. Using stool and rectal swabs are, thus, the most reliable ... Enterobacteriaceae are common commensals and infectious agents. Experts fear CRE as the new "superbug". The bacteria can kill ...

https://en.wikipedia.org/wiki/Carbapenem-resistant_enterobacteriaceae

Soft rot Enterobacteriaceae (SRE) (spanning the genera Erwinia, Pectobacterium, Dickeya, and Pantoea), are ubiquitous ...

https://en.wikipedia.org/wiki/Soft_rot_Enterobacteriaceae_(SRE)_small_RNAs

Donnenberg, Michael (2015). "Enterobacteriaceae". Mandell, Douglas, and Bennett's Principles and Practice of Infectious ... Donnenberg, Michael (2009). "Chapter 218: Enterobacteriaceae". Mandell, Douglas, and Bennett's Principles and Practice of ... insights into a highly versatile and diverse genus within the Enterobacteriaceae". FEMS Microbiology Reviews. 39 (6): 968-984. ...

https://en.wikipedia.org/wiki/Pantoea

"Enterobacteriaceae". NICD. Retrieved 2022-12-03. Roper MC (September 2011). "Pantoea stewartii subsp. stewartii: lessons ...

https://en.wikipedia.org/wiki/Pantoea_stewartii

Enterobacteriaceae). This fly is also infected with a variety of viruses in the wild. Whilst sharing some natural viruses with ...

https://en.wikipedia.org/wiki/Drosophila_suzukii

"Enterobacteriaceae" (PDF). Louisiana Department of Health. Retrieved 29 April 2020. Fusco, Vincenzina; Abriouel, Hikmate; ... a metabolic enzyme ADP glucose pyrophosphorylase with distinct kinetic properties from those found in Enterobacteriaceae in ...

https://en.wikipedia.org/wiki/Serratia

Ryan, Kenneth James (2018). "Chapter 33: Enterobacteriaceae". Sherris Medical Microbiology (7th ed.). McGraw-Hill Professional ... Enterobacteriaceae)". Jawetz, Melnick, & Adelberg's Medical Microbiology (27 ed.). McGraw-Hill Professional Med/Tech. Germani, ... Enterobacteriaceae, Bacteria described in 1919, All stub articles, Enterobacterales stubs). ...

https://en.wikipedia.org/wiki/Shigella_dysenteriae

Some Enterobacteriaceae, Pseudomonas spp., Enterococcus spp., Staphylococcus aureus and other Staphylococcus spp. have varying ...

https://en.wikipedia.org/wiki/Gentamicin

These are generally B. fragilis group, Clostridium spp., Enterobacteriaceae and Enterococcus spp. On the other hand, infections ... The aerobic bacteria also found mixed with these anaerobic bacteria include Enterobacteriaceae, Streptococcus spp. (including ... where they are often isolated along with Enterobacteriaceae, Pseudomonas spp. and Staphylococcus aureus. It is important that ...

https://en.wikipedia.org/wiki/Anaerobic_infection

Enterobacteriaceae are typically OX−. The test uses disks impregnated with a reagent such as N,N,N′,N′-tetramethyl-p- ... May 1981). "Kluyvera, a new (redefined) genus in the family Enterobacteriaceae: identification of Kluyvera ascorbata sp. nov. ...

https://en.wikipedia.org/wiki/Oxidase_test

"Enterobacteriaceae, Vibrio, Campylobacter and Helicobacter". Archived from the original on 24 December 2008. Retrieved 2008-12- ... It is associated with species of bacteria from the family Enterobacteriaceae. The term is usually restricted to Shigella ...

https://en.wikipedia.org/wiki/Bacillary_dysentery

Enterobacteriaceae are also commonly found. With multi-species biofilms also commonly encountered. If an infection settles on a ...

https://en.wikipedia.org/wiki/Surgical_mesh

Farmer JJ III, Asbury MA, Hickman FW, Brenner DJ (1980). the Enterobacteriaceae Study Group (USA). "Enterobacter sakazakii: a ... Caubilla-Barron J, Forsythe S (2007). "Dry stress and survival time of Enterobacter sakazakii and other Enterobacteriaceae in ... This resulted in the classification of E. sakazakii as a new genus, Cronobacter within the Enterobacteriaceae, initially ... new species of "Enterobacteriaceae" isolated from clinical specimens". Int J Syst Bacteriol. 30 (3): 569-84. doi:10.1099/ ...

https://en.wikipedia.org/wiki/Cronobacter_sakazakii

He did important research on the taxonomy of the family Enterobacteriaceae. Stuart was elected in 1933 a fellow of the American ... Borman, Earle K.; Stuart, C. A.; Wheeler, Kenneth M. (1944). "Taxonomy of the Family Enterobacteriaceae". Journal of ... an Anaerogenic Group in the Enterobacteriaceae". The Journal of Infectious Diseases. 84 (3): 235-239. doi:10.1093/infdis/84.3. ...

https://en.wikipedia.org/wiki/Charles_Arthur_Stuart

... is a genus of extremely rare bacteria of the family Enterobacteriaceae. The name of this genus was derived from CDC, ... nov., New Enterobacteriaceae from Clinical Specimens". Int J Syst Bacteriol. 31 (3): 317-326. doi:10.1099/00207713-31-3-317. ... Lapage has also made many contributions to the family Enterobacteriaceae. Cedecea neteri was named after Erwin Neter. Neter is ... nov., New Enterobacteriaceae from clinical specimens. International Journal of Systematic Bacteriology 31, 317-326. Mawardi, H ...

https://en.wikipedia.org/wiki/Cedecea

algC motifs are found in Enterobacteriaceae. algC motif RNAs likely function as cis-regulatory elements, in view of their ...

https://en.wikipedia.org/wiki/AlgC_RNA_motif

Bouet, Jean-Yves; Funnell, Barbara E. (2019-06-19). "Plasmid Localization and Partition in Enterobacteriaceae". EcoSal Plus. 8 ...

https://en.wikipedia.org/wiki/Plasmid_partition_system

Enterobacteriaceae. In: Manual of Clinical Microbiology (6th Edition). Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH ( ... nov., new Enterobacteriaceae from clinical specimens. International Journal of Systematic Bacteriology. 31, 317-326 (1981). ... Enterobacter hormaechei, a new species of the family Enterobacteriaceae formerly known as enteric group 75. Journal of Clinical ... 22, 4-11 (1972). Farmer JJ III, Asbury MA, Hickman FW, Brenner DJ; Enterobacteriaceae Study Group. Enterobacter sakazakii: a ...

https://en.wikipedia.org/wiki/Enterobacter_cloacae

Springer Science+Business Media, LLC 2011 DOI 10.1007/978-1-4419-7686-4_2 Brenner DJ (1984). "Family I. Enterobacteriaceae Rahn ...

https://en.wikipedia.org/wiki/Bacillus

If used they should target enteric organisms (e.g. Enterobacteriaceae), such as E. coli and Bacteroides. This may consist of a ...

https://en.wikipedia.org/wiki/Cholecystitis

Articles with 'species' microformats, Enterobacteriaceae, Candidatus taxa). ...

https://en.wikipedia.org/wiki/Blochmannia

nov., A Novel Member of the Family Enterobacteriaceae". Current Microbiology. 56 (6): 603-608. doi:10.1007/s00284-008-9133-9. v ...

https://en.wikipedia.org/wiki/Biostraticola

The bacterium is a member of Enterobacteriaceae. It is capable of producing enterotoxins which are thermolabile or thermostable ...

https://en.wikipedia.org/wiki/Mesophile

"Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections". Open Forum Infectious Diseases. 2 (2): ofv050. doi: ... "Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections". Open Forum Infectious Diseases. 2 (2): ofv050. doi: ...

https://en.wikipedia.org/wiki/Kerry_LaPlante

Infection with carbapenem-resistant Enterobacteriaceae (CRE) or carbapenemase-producing Enterobacteriaceae is emerging as an ... In the clinical setting, it is the most significant member of the genus Klebsiella of the Enterobacteriaceae. K. oxytoca and K ... "Carbapenem-resistant Enterobacteriaceae (CRE) Infection: Clinician FAQs". Cdc.gov. Retrieved 25 October 2017. "Guideline for ... A number of mechanisms cause carbapenem resistance in the Enterobacteriaceae. These include hyperproduction of ampC beta- ...

https://en.wikipedia.org/wiki/Klebsiella_pneumoniae

"Activity of faropenem against cephalosporin-resistant Enterobacteriaceae". J. Antimicrob. Chemother. 59 (5): 1025-30. doi: ...

https://en.wikipedia.org/wiki/Faropenem

Datta A, Prescott LM (1969). "Effect of Vibriocins on Members of the Enterobacteriaceae". Journal of Bacteriology. 98 (2): 849- ...

https://en.wikipedia.org/wiki/Vibriocin

A particular strength is its activity against Enterobacteriaceae. Whereas other cephalosporins are degraded by many plasmid- ... and chromosome-mediated beta-lactamases, cefepime is stable and is a front-line agent when infection with Enterobacteriaceae is ...

https://en.wikipedia.org/wiki/Cefepime

divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., ...

https://en.wikipedia.org/wiki/Providencia_(bacterium)

... expands guidelines for preventing the spread of carbapenem-resistant Enterobacteriaceae, organisms said to be on the rise. ... "New Carbapenem-Resistant Enterobacteriaceae Warrant Additional Action by Healthcare Providers." CDC. Full text ... Citing increased reports of carbapenem-resistant Enterobacteriaceae (CRE), the Centers for Disease Control and Prevention (CDC ...

http://www.medscape.com/viewarticle/779586

Carbapenem-resistant Enterobacteriaceae (CRE) are untreatable or difficult-to-treat multidrugresistant organisms that are ... Centers for Disease Control and Prevention (U.S.) "New carbapenem-resistant Enterobacteriaceae warrant additional action by ... Centers for Disease Control and Prevention (U.S.) "New carbapenem-resistant Enterobacteriaceae warrant additional action by ... Centers for Disease Control and Prevention (U.S.) (2013). New carbapenem-resistant Enterobacteriaceae warrant additional action ...

https://emergency.cdc.gov/han/han00341.asp

... manual supporting implementation of the Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, ...

https://extranet.who.int/iris/restricted/browse?authority=Enterobacteriaceae&type=mesh

Enterobacteriaceae bacterium CC8I1. Taxonomy ID: 1556519 (for references in articles please use NCBI:txid1556519). current name ... cellular organisms; Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; unclassified ...

https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=1556519&lvl=3&lin=f&keep=1&srchmode=1&unlock

Enterobacteriaceae bacterium HRRK081. Taxonomy ID: 1635651 (for references in articles please use NCBI:txid1635651). current ... cellular organisms; Bacteria; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; unclassified ...

https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&id=1635651&lvl=3&lin=f&keep=1&srchmode=1&unlock

Mutations in chromosomal genes contribute to antibiotic resistance, but Enterobacteriaceae are ad … ... Enterobacteriaceae are responsible for a large proportion of serious, life-threatening infections and resistance to multiple ... Resistance mechanisms in Enterobacteriaceae Sally R Partridge. Pathology. 2015 Apr. Show details Display options Display ... Resistance in gram-negative bacteria: enterobacteriaceae. Paterson DL. Paterson DL. Am J Med. 2006 Jun;119(6 Suppl 1):S20-8; ...

https://pubmed.ncbi.nlm.nih.gov/25764207

Carbapenem-resistant Enterobacteriaceae (CRE) are untreatable or difficult-to-treat multidrug resistant organisms that are ... Centers for Disease Control and Prevention (U.S.) "New carbapenem-resistant Enterobacteriaceae warrant additional action by ... Centers for Disease Control and Prevention (U.S.) "New carbapenem-resistant Enterobacteriaceae warrant additional action by ... Centers for Disease Control and Prevention (U.S.) (2013). New carbapenem-resistant Enterobacteriaceae warrant additional action ...

https://stacks.cdc.gov/view/cdc/25250?CDC_AA_refVal=https%3A%2F%2Femergency.cdc.gov%2Fhan%2Fhan00341.asp

Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase-producing Enterobacteriaceae and Infection after Liver Transplant ... Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase-producing Enterobacteriaceae and Infection after Liver Transplant ... Escherichia coli isolates from 6 patients examined during study of extended-spectrum β-lactamase-producing Enterobacteriaceae ...

https://wwwnc.cdc.gov/eid/article/18/6/11-0139-f1.htm

Integrons in Enterobacteriaceae: diversity, distribution and epidemiology. Kaushik M, Kumar S, Kapoor RK, Virdi JS, Gulati P. ... Molecular epidemiology of integron-associated antibiotic resistance genes in clinical isolates of enterobacteriaceae B Sallen 1 ... Molecular epidemiology of integron-associated antibiotic resistance genes in clinical isolates of enterobacteriaceae B Sallen ... Rapid screening technique for class 1 integrons in Enterobacteriaceae and nonfermenting gram-negative bacteria and its use in ...

https://pubmed.ncbi.nlm.nih.gov/9158775

unclassified Enterobacteriaceae. T02431. ebf. Enterobacteriaceae bacterium FGI 57. T05417. ebc. Enterobacteriaceae bacterium ...

https://www.genome.jp/kegg-bin/show_organism?category=unclassified%20Enterobacteriaceae

Participating acute care facilities across Canada submitted carbapenem-nonsusceptible Enterobacteriaceae from 1 January 2010 to ... Carbapenemase-producing Enterobacteriaceae (CPE) are increasing globally; here we report on the investigation of CPE in Canada ... Overall national carbapenem-resistant Enterobacteriaceae (CRE) and carbapenemase-producing Enterobacteriaceae (CPE) rates per ... Overall national carbapenem-resistant Enterobacteriaceae (CRE) and carbapenemase-producing Enterobacteriaceae (CPE) rates per ...

https://pubmed.ncbi.nlm.nih.gov/27600052

... J Med Microbiol. 2011 Jun;60(Pt 6):715-721. doi: ... detection in a collection of 246 Enterobacteriaceae with a diverse range of β-lactam resistance profiles. The Bla(AmpC) ...

https://pubmed.ncbi.nlm.nih.gov/21372181/

... and TEM-1-producing Enterobacteriaceae strains containing the aac(6)-Ib-cr gene, which encodes an aminoglycoside- and ... Appearance of aac(6)-Ib-cr gene among extended-spectrum beta-lactamase-producing Enterobacteriaceae in a French hospital. ... Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Cantón R, Novais A, Valverde ... Dissemination in Portugal of CTX-M-15-, OXA-1-, and TEM-1-producing Enterobacteriaceae strains containing the aac(6)-Ib-cr ...

https://pubmed.ncbi.nlm.nih.gov/16940136

CTX-M-15 extended-spectrum β-lactamases in Enterobacteriaceae in the intensive care unit of Tlemcen Hospital, Algeria ... In all, 28 Enterobacteriaceae isolates were isolated from specimens recovered from patients in the ICU and 2 from surfaces of ... CTX-M-15 extended-spectrum β-lactamases in Enterobacteriaceae in the intensive care unit of Tlemcen Hospital, Algeria ... Clinical isolates of Enterobacteriaceae producing extended-spectrum β-lactamases: prevalence of CTX-M-3 at a hospital in China ...

https://www.emro.who.int/emhj-volume-18-2012/issue-4/article-13.html

... Description. ESBL (Extended spectrum beta-lactamase ... ESBL (Extended spectrum beta-lactamase producing Enterobacteriaceae) Quantitative Culture. EMSL Test Code: M732. ... producing Enterobacteriaceae) Presence/Absence Culture. EMSL Test Code: M731. ...

https://emsl.com/Services.aspx?action=show&serviceid=1686&char=E&bcl=4

"Enterobacteriaceae Infections" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH ( ... This graph shows the total number of publications written about "Enterobacteriaceae Infections" by people in Harvard Catalyst ... Below are the most recent publications written about "Enterobacteriaceae Infections" by people in Profiles. ... Below are MeSH descriptors whose meaning is more general than "Enterobacteriaceae Infections". ...

https://connects.catalyst.harvard.edu/Profiles/display/Concept/Enterobacteriaceae%20Infections

CRACKLE: Carbapenems in Klebsiella pneumoniae and Other Enterobacteriaceae. The Consortium on Resistance Against Carbapenems in ... Klebsiella and other Enterobacteriaceae (CRACKLE) is a federally funded, prospective multi-center consortium to track ...

https://www.jcvi.org/research/crackle-carbapenems-klebsiella-pneumoniae-and-other-enterobacteriaceae

FROM THE PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES Asymptomatic carriage of carbapenem-resistant Enterobacteriaceae is ... Asymptomatic carriage of carbapenem-resistant Enterobacteriaceae is "considerable," according to genetic analyses of bacterial ...

https://www.pm360online.com/asymptomatic-carriage-of-carbapenem-resistant-enterobacteriaceae-considerable/

Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control. 2013;41:190- ... The Epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace. J Infect Dis. 2017; ... Rapid global dissemination of carbapenemase-producing Enterobacteriaceae (CPE) poses a public health threat (1). To prevent the ... Duration of Carbapenemase-Producing Enterobacteriaceae Carriage in Hospital Patients On This Page ...

https://wwwnc.cdc.gov/eid/article/26/9/19-0592_article

Carbapenem-resistant Enterobacteriaceae Testing Market: Overview In Carbapenem-resistant Enterobacteriaceae Testing, Modified ... These are called Carbapenem-resistant Enterobacteriaceae. Carbapenem-resistant Enterobacteriaceae Testing Market is considered ... for Carbapenem-resistant enterobacteriaceae testing, synergy Carbapenem-resistant enterobacteriaceae testing, modified Hodge ... Enterobacteriaceae are a family of germs that most commonly live in a persons bowel without causing any disease. Carbapenems ...

https://www.ukprwire.com/Detailed/Business/Carbapenem-resistant_Enterobacteriaceae_Testing_Market_Projections_Highlighting_Primary_Trends_until_391806.shtml

Carbapenem-resistant Enterobacteriaceae (CRE) are untreatable or difficult-to-treat multidrug resistant organisms that are ... Centers for Disease Control and Prevention (U.S.) "New carbapenem-resistant Enterobacteriaceae warrant additional action by ... Centers for Disease Control and Prevention (U.S.) "New carbapenem-resistant Enterobacteriaceae warrant additional action by ... Centers for Disease Control and Prevention (U.S.) (2013). New carbapenem-resistant Enterobacteriaceae warrant additional action ...

https://tools.cdc.gov/podcasts/download.asp?m=320671&c=357012

Meanwhile, the mean values of Enterobacteriaceae sp. counts (log10 cfu g-1) in Ras cheese was 2.48, in Kareish cheese was 6.78 ... All samples were examined for presence of Staphylococcus aureus (on Baird Parker agar medium) and Enterobacteriaceae sp. (on ... Prevalence and Significance of Staphylococcus aureus and Enterobacteriaceae species in Selected Dairy Products and Handlers ... The prevalence and significance of Staphylococcus aureus and Enterobacteriaceae species in Ras cheese, Kareish cheese and ice ...

https://scialert.net/abstract/index.php?doi=ijds.2009.100.108

Phenotypic and genotypic correlation of carbapenememase-producing Enterobacteriaceae and problems experienced in routine ...

http://www.samj.org.za/index.php/samj/article/view/12303/8491

The prevalence of extended-spectrum β-lactamase- (ESBL) producing Enterobacteriaceae (EPE) and carbapenemase-producing ... and carbapenemase-producing Enterobacteriaceae. This thesis also demonstrates the performance of a rapid phenotypic ... Klebsiella pneumoniae and Escherichia coli are two of the most clinically important pathogens of the family Enterobacteriaceae ... Enterobacteriaceae (CPE) are increasing worldwide. This is a severe threat to public health, as antibiotic treatment becomes ...

https://www.dissertations.se/dissertation/3a02c096dc/

Number of results to display per page ...

https://collections.nlm.nih.gov/?f%5Bdrep2.subjectAggregate%5D%5B%5D=Enterobacteriaceae&per_page=10&sort=drep3.titleSortForm+asc

Construction of stable fluorescent laboratory control strains for several food safety relevant Enterobacteriaceae. Authors: ...

https://www.pacb.com/publications/construction-of-stable-fluorescent-laboratory-control-strains-for-several-food-safety-relevant-enterobacteriaceae/

FECAL MICROBIOTA TRANSPLANTATION; CEPHALOSPORIN-RESISTANT ENTEROBACTERIACEAE; LACTAMASE-PRODUCING ENTEROBACTERIACEAE; SELECTIVE ... Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, ... Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, ...

https://kups.ub.uni-koeln.de/13638/

Carbapenem-resistant Enterobacteriaceae (CRE). Enterobacteriaceae, such as Klebsiella pneumoniae and Escherichia coli (E. coli ... Other Enterobacteriaceae can be resistant to carbapenems, which are considered drugs of last resort. Enterobacteriaceae-related ... Some Enterobacteriaceae contain an enzyme called extended-spectrum β-lactamase (ESBL) which makes them resistant to nearly all ... However, some people can have Enterobacteriaceae in their body without it causing any disease. Read more about NIAID research ...

https://www.niaid.nih.gov/node/12329

DeathsAttributabletoCRE Enterobacteriaceae with susceptible isolates) were excluded, as were studies Statistical Analysis that compared patients who had carbapenem-resistant in- We calculated pooled risk ratios (RRs) and 95% CIs fections with patients who were not infected. (cdc.gov)
Enterobacterial repetitive intergenic consensus sequence type 2 PCR patterns of pairs of Escherichia coli isolates from 6 patients examined during study of extended-spectrum β-lactamase-producing Enterobacteriaceae infection among liver transplant recipients, France, January 2001-April 2010. (cdc.gov)
ABSTRACT The aim of this study was to detect extended-spectrum β-lactamases (ESBL) in Enterobacteriaceae isolates in the intensive care unit (ICU) of Tlemcen hospital in north-western Algeria. (who.int)
In all, 28 Enterobacteriaceae isolates were isolated from specimens recovered from patients in the ICU and 2 from surfaces of the unit. (who.int)
In this study, we molecularly characterized 12 NDM-1 producing clinical Enterobacteriaceae ( Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae ) isolates that were part of a collection of non-carbapenem susceptible isolates obtained during a one-year period. (who.int)
Teo J, Ngan G, Balm M, Jureen R, Krishnan P, Lin R. Molecular characterization of NDM-1 producing Enterobacteriaceae isolates in Singapore hospitals. (who.int)
Methods From November 2011 to April 2012, 71 laboratories recorded non-duplicate Enterobacteriaceae clinical isolates NS to at least one carbapenem and the total number of isolates of the different species. (elsevier.com)
Results During the study period, the 71 laboratories identified 133 244 Enterobacteriaceae isolates, of which 846 (0.63%) were NS to at least one carbapenem. (elsevier.com)
on behalf of ONERBA's Carbapenem Resistance Study Group 2014, ' Incidence rates of carbapenemase-producing Enterobacteriaceae clinical isolates in France: A prospective nationwide study in 2011-12 ', Journal of Antimicrobial Chemotherapy , vol. 69, no. 10, pp. 2706-2712. (elsevier.com)

Enterobacteriaceae are responsible for a large proportion of serious, life-threatening infections and resistance to multiple antibiotics in these organisms is an increasing global public health problem. (nih.gov)
Enterobacteriaceae Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (harvard.edu)
Infections with bacteria of the family ENTEROBACTERIACEAE. (harvard.edu)
This graph shows the total number of publications written about "Enterobacteriaceae Infections" by people in Harvard Catalyst Profiles by year, and whether "Enterobacteriaceae Infections" was a major or minor topic of these publication. (harvard.edu)
Below are the most recent publications written about "Enterobacteriaceae Infections" by people in Profiles. (harvard.edu)
A few infections caused by carbapenem-resistant Enterobacteriaceae outside the bowel include wound infection, urinary tract infection (UTI) and pneumonia. (ukprwire.com)
Enterobacteriaceae , such as Klebsiella pneumoniae and Escherichia coli ( E. coli ) can cause serious infections of the urinary tract, bloodstream and wounds, and can also cause pneumonia. (nih.gov)
Background: Pediatric bloodstream infections (BSIs) with Extended-Spectrum Beta-Lactamase- producing Enterobacteriaceae (ESBL-PE) are associated with worse clinical outcomes. (houstonmethodist.org)
Ming DK, Otter JA, Ghani R, Brannigan ET, Boonyasiri A, Mookerjee S, Gilchrist M, Holmes AH, Davies F. Clinical risk stratification and antibiotic management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections in the UK. (uams.edu)

Citing increased reports of carbapenem-resistant Enterobacteriaceae (CRE), the Centers for Disease Control and Prevention (CDC) has expanded guidelines aimed at preventing the spread of these difficult-to-treat, multidrug-resistant organisms. (medscape.com)
According to The Centers for Disease Control and Prevention (CDC), by 2013 Carbapenem-resistant enterobacteriaceae was found in almost 42 states. (ukprwire.com)

The Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacteriaceae (CRACKLE) is a federally funded, prospective multi-center consortium to track carbapenem-resistant Enterobacteriacea . (jcvi.org)
Klebsiella pneumoniae and Escherichia coli are two of the most clinically important pathogens of the family Enterobacteriaceae. (dissertations.se)

The prevalence of extended-spectrum β-lactamase- (ESBL) producing Enterobacteriaceae (EPE) and carbapenemase-producing Enterobacteriaceae (CPE) are increasing worldwide. (dissertations.se)
Some Enterobacteriaceae contain an enzyme called extended-spectrum β-lactamase (ESBL) which makes them resistant to nearly all penicillins and cephalosporins. (nih.gov)

The ease of NDM-1 plasmid transmissibility may help their dissemination among the Enterobacteriaceae. (who.int)
Monitoring and preventing dissemination of this azithromycin resistance-encoding conjugative plasmid in Enterobacteriaceae is of utmost importance. (edu.hk)

Other Enterobacteriaceae can be resistant to carbapenems, which are considered drugs of last resort. (nih.gov)
Objectives To determine proportions and incidence rates of Enterobacteriaceae producing carbapenemase among those non-susceptible (NS) to carbapenems in France. (elsevier.com)

Rapid global dissemination of carbapenemase-producing Enterobacteriaceae (CPE) poses a public health threat ( 1 ). (cdc.gov)

Producing Enterobacteriaceae and OXA-23-Producing Acinetobacter baumannii Sequence Type 2 in Tunisian Seafood. (bvsalud.org)

Carbapenem-resistant enterobacteriaceae testing includes disc diffusion or automated systems, selective agar Carbapenem-resistant enterobacteriaceae testing, minimal inhibitory concentration (MIC) for Carbapenem-resistant enterobacteriaceae testing, synergy Carbapenem-resistant enterobacteriaceae testing, modified Hodge tests, whole genome sequencing, spectrometrics and various other molecular methods. (ukprwire.com)
All samples were examined for presence of Staphylococcus aureus (on Baird Parker agar medium) and Enterobacteriaceae sp. (scialert.net)

The prevalence and significance of Staphylococcus aureus and Enterobacteriaceae species in Ras cheese, Kareish cheese and ice cream samples and in swabs of dairy handlers in Ismailia city were studied. (scialert.net)

Mutations in chromosomal genes contribute to antibiotic resistance, but Enterobacteriaceae are adapted to sharing genetic material and much important resistance is due to 'mobile' resistance genes. (nih.gov)
This study compared the sensitivity and specificity of phenotypic methods of Bla(AmpC) detection in a collection of 246 Enterobacteriaceae with a diverse range of β-lactam resistance profiles. (nih.gov)
Growing awareness about prevention of Carbapenem resistance and increased efforts by governments through the implementation of infection prevention and control measures might hinder the growth of the Carbapenem-resistant enterobacteriaceae testing market during the forecast period. (ukprwire.com)

We evaluated the number of deaths attributable to care facilities around the world ( 6 - 13 ), and in some plac- carbapenem-resistant Enterobacteriaceae by using studies es, CRE have become endemic ( 14 - 18 ). (cdc.gov)
Healthy travellers to countries where carbapenemases-producing Enterobacteriaceae (CPE) are endemic might be at risk for their acquisition, even without contact with the local healthcare system. (pasteur.fr)

Appearance of aac(6')-Ib-cr gene among extended-spectrum beta-lactamase-producing Enterobacteriaceae in a French hospital. (nih.gov)

We performed a systematic search in the PubMed arbapenem-resistant strains have emerged among spe- (http://www.ncbi.nlm.nih.gov/pubmed/) and Scopus cies belonging to the Enterobacteriaceae family ( 1 , 2 ). (cdc.gov)
Construction of stable fluorescent laboratory control strains for several food safety relevant Enterobacteriaceae. (pacb.com)

Results of search for 'su:{Enterobacteriaceae. (who.int)

Isolation demand from carbapenemase-producing Enterobacteriaceae screening strategies based on a West London hospital network. (uams.edu)

Increase in the number of people requiring inpatient medical assistance, growing number of healthcare facilities, increased number of complex surgeries, multiple use of several antibiotics and rise in use of medical devices in the body, such as urinary catheters, intravenous catheters and ventilators, are few of the major factors responsible for growth in the Carbapenem-resistant enterobacteriaceae testing market. (ukprwire.com)
Enterobacteriaceae -related disease usually occurs in patients at healthcare facilities who have weak immune systems, are on breathing machines or use urinary or intravenous catheters. (nih.gov)

abstract = "We compared the Rodac imprint technique to selective enrichment broth for detecting vancomycin-resistant enterococci (VRE) and multidrug-resistant Enterobacteriaceae (MDRE) on surfaces. (northwestern.edu)

To determine the duration of carbapenemase-producing Enterobacteriaceae (CPE) carriage, we studied 21 CPE carriers for »1 year. (cdc.gov)

Carbapenem-resistant Enterobacteriaceae (CRE) are a major concern for patients in healthcare facilities. (cdc.gov)
New Carbapenem-Resistant Enterobacteriaceae Warrant Additional Action by Healthcare Providers. (medscape.com)
Cite this: Carbapenem-Resistant Enterobacteriaceae: New Precautions - Medscape - Feb 19, 2013. (medscape.com)
These are called Carbapenem-resistant Enterobacteriaceae. (ukprwire.com)
Carbapenem-resistant Enterobacteriaceae Testing Market is considered to be a gram-negative pathogen testing. (ukprwire.com)
People prone to Carbapenem-resistant enterobacteriaceae include people admitted to hospitals or other healthcare settings. (ukprwire.com)
People admitted to any healthcare setting for medical care are more prone to infection and to go for Carbapenem-resistant enterobacteriaceae testing than healthy people. (ukprwire.com)
In Carbapenem-resistant Enterobacteriaceae Testing, Modified Hodge tests are anticipated to be one of the leading test types for Carbapenem-resistant enterobacteriaceae testing because of high accuracy of test results. (ukprwire.com)
These tests are easy to perform and can be performed in a routine laboratory, which makes them more feasible and thus, one of the leading test types in Carbapenem-resistant enterobacteriaceae testing market. (ukprwire.com)
Healthcare settings, such as nursing homes and acute care centers, where constant medical care is required for a longer duration of time are more prone to CRE and thus, the demand for Carbapenem-resistant enterobacteriaceae testing is higher in these settings. (ukprwire.com)

Evaluating serial screening cultures to detect carbapenemase-producing Enterobacteriaceae following hospital admission. (uams.edu)

Enterobacteriaceae are a family of germs that most commonly live in a person's bowel without causing any disease. (ukprwire.com)

However, some people can have Enterobacteriaceae in their body without it causing any disease. (nih.gov)

fr]En cliquant sur « Accepter tous les cookies », vous acceptez le stockage de cookies sur votre appareil pour améliorer la navigation sur le site, analyser son utilisation et contribuer à nos efforts de marketing pour soutenir la recherche. (pasteur.fr)

Anatomy4

Organisms37

Diseases10

Chemicals and Drugs58

Analytical, Diagnostic and Therapeutic Techniques and Equipment18

Phenomena and Processes15

Disciplines and Occupations2

Anthropology, Education, Sociology and Social Phenomena1

Technology, Industry, Agriculture1

Information Science3

Health Care8

Geographicals1

UK-18892, a new aminoglycoside: an in vitro study. (1/3467)

Ciprofloxacin decreases the rate of ethanol elimination in humans. (2/3467)

Sodalis gen. nov. and Sodalis glossinidius sp. nov., a microaerophilic secondary endosymbiont of the tsetse fly Glossina morsitans morsitans. (3/3467)

High turnover rate of Escherichia coli strains in the intestinal flora of infants in Pakistan. (4/3467)

The influence of a diet rich in wheat fibre on the human faecal flora. (5/3467)

Use of an isogenic Escherichia coli panel to design tests for discrimination of beta-lactamase functional groups of Enterobacteriaceae. (6/3467)

Many class I integrons comprise distinct stable structures occurring in different species of Enterobacteriaceae isolated from widespread geographic regions in Europe. (7/3467)

Functional importance and local environments of the cysteines in the tetracycline resistance protein encoded by plasmid pBR322. (8/3467)

No images available that match "enterobacteriaceae"

Enterobacteriaceae

Enterobacteriaceae Infections

beta-Lactamases

Microbial Sensitivity Tests

Anti-Bacterial Agents

beta-Lactam Resistance

Enterobacter

Serratia

Proteus

Carbapenems

Bacteriological Techniques

Klebsiella

Escherichia

Klebsiella pneumoniae

beta-Lactams

Cephalosporins

Gram-Negative Bacteria

Citrobacter

Bacteria

Escherichia coli

Drug Resistance, Bacterial

Drug Resistance, Multiple, Bacterial

Drug Resistance, Microbial

Salmonella

Enterobacter cloacae

Klebsiella Infections

Serratia marcescens

Bacterial Proteins

DNA, Bacterial

Gram-Negative Bacterial Infections

Vibrionaceae

Evaluation Studies as Topic

Aztreonam

Cefotaxime

Ceftazidime

Proteus mirabilis

Klebsiella oxytoca

Providencia

Shigella

Cephalosporin Resistance

Culture Media

Kluyvera

Pseudomonadaceae

Citrobacter freundii

Feces

Pseudomonas aeruginosa

Penicillanic Acid

Cross Infection

Thienamycins

Azabicyclo Compounds

Conjugation, Genetic

Quinolones

Plasmids

Gram-Positive Bacteria

Imipenem

Erwinia

Bacteria, Aerobic

Anti-Infective Agents

Clavulanic Acid

Bacterial Infections

Aminoglycosides

Amikacin

Bacteremia

Acinetobacter

Antisepsis

Piperacillin

Fluoroquinolones

Sequence Analysis, DNA

Hospitals

Kanamycin

Ciprofloxacin

Minocycline

Gene Transfer, Horizontal

Disk Diffusion Antimicrobial Tests

Gentamicins

Integrons

Species Specificity

Yersinia

Chromogenic Compounds

Genes, Bacterial